Lido Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $321K | Buy |
19,141
+43
| +0.2% | +$721 | ﹤0.01% | 1174 |
|
|
2025
Q1 | $294K | Sell |
19,098
-66
| -0.3% | -$1.01K | ﹤0.01% | 1132 |
|
|
2024
Q4 | $422K | Sell |
19,164
-42
| -0.2% | -$926 | ﹤0.01% | 973 |
|
|
2024
Q3 | $346K | Buy |
19,206
+631
| +3% | +$11.4K | ﹤0.01% | 987 |
|
|
2024
Q2 | $302K | Sell |
18,575
-669
| -3% | -$10.9K | ﹤0.01% | 1004 |
|
|
2024
Q1 | $272K | Sell |
19,244
-124
| -0.6% | -$1.75K | ﹤0.01% | 1034 |
|
|
2023
Q4 | $202K | Buy |
19,368
+2,556
| +15% | +$26.7K | ﹤0.01% | 1097 |
|
|
2023
Q3 | $171K | Buy |
16,812
+298
| +2% | +$3.04K | ﹤0.01% | 974 |
|
|
2023
Q2 | $124K | Sell |
16,514
-262
| -2% | -$1.97K | ﹤0.01% | 999 |
|
|
2023
Q1 | $148K | Buy |
+16,776
| New | +$148K | ﹤0.01% | 929 |
|